Disposition of 67349 shares by Stephen Ma of Scilex Holding at 1.73 subject to Rule 16b-3
| SCLX Stock | 0.59 0.02 3.51% |
Slightly above 54% of Scilex Holding's investors are presently thinking to get in. The analysis of overall sentiment of trading Scilex Holding stock suggests that some investors are interested at this time. Scilex Holding's investing sentiment can be driven by a variety of factors including economic data, Scilex Holding's earnings reports, geopolitical events, and overall market trends.
Scilex |
Filed transaction by Scilex Holding Officer: Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Scilex Holding Fundamental Analysis
We analyze Scilex Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Scilex Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Scilex Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
Scilex Holding is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Scilex Holding Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Scilex Holding stock to make a market-neutral strategy. Peer analysis of Scilex Holding could also be used in its relative valuation, which is a method of valuing Scilex Holding by comparing valuation metrics with similar companies.
Peers
Scilex Holding Related Equities
| MRK | Merck | 1.50 | ||||
| AMGN | Amgen | 0.24 | ||||
| GILD | Gilead Sciences | 0.04 | ||||
| NVS | Novartis | 0.58 | ||||
| BMY | Bristol Myers | 0.65 | ||||
| ABBV | AbbVie | 0.68 | ||||
| AZN | AstraZeneca PLC | 0.68 | ||||
| GSK | GlaxoSmithKline PLC | 0.81 | ||||
| BIIB | Biogen | 1.35 | ||||
| LLY | Eli Lilly | 1.72 | ||||
| SNY | Sanofi ADR | 2.08 |
Additional Tools for Scilex Stock Analysis
When running Scilex Holding's price analysis, check to measure Scilex Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scilex Holding is operating at the current time. Most of Scilex Holding's value examination focuses on studying past and present price action to predict the probability of Scilex Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scilex Holding's price. Additionally, you may evaluate how the addition of Scilex Holding to your portfolios can decrease your overall portfolio volatility.